BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Altogether this study describes a novel PTPRG-dependent regulative loop involving critical regulatory components of the BCR-ABL1 signaling pathway (Figure 6), further strengthening the role of PTPRG as a crucial tumor suppressor in CML cells and a possible candidate for specific therapies aimed at its re-expression or activation.